InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Baldasare Bryan T, Chief Financial Officer. Officer active across 1 companies, notably Meridian Bioscience INC. Cumulatively, 8 disclosures have been recorded. The latest transaction was filed on 15 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
€31,5871,985 shares@ €15.91332.0% of flow
Common Stock
SEC:0001127602-21-031730·
€31,5871,985 shares@ €15.9130.041% mcap16.0% of flow
Common Stock
SEC:0001127602-21-031730:0·
€67,0793,807 shares@ €17.619868.0% of flow
Common Stock
SEC:0001127602-21-031110·
€67,0793,807 shares@ €17.61980.088% mcap34.0% of flow
Common Stock
SEC:0001127602-21-031110:0·
32,557 shares
Common Stock
SEC:0001127602-21-029298·
32,557 shares
Common Stock
SEC:0001127602-21-029298:0·
010,593 shares0
Common Stock
SEC:0001127602-21-028575·
010,593 shares0
Common Stock
SEC:0001127602-21-028575:0·
8 of 8 declarations
About Baldasare Bryan T
Bryan T. Baldasare is the Chief Financial Officer at Meridian Bioscience Inc. In this role, he is responsible for managing the company's finances, including financial planning and risk management. Bryan plays a crucial role in developing financial strategies to ensure the stability and growth of the organization.
